Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma

The molecular characterization of endometrial carcinoma (EC) has recently been included in the ESGO/ESTRO/ESP guidelines. The study aims to evaluate the impact of integrated molecular and pathologic risk stratification in the clinical practice and the relevance of pathologic parameters in predicting...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of personalized medicine 2023-04, Vol.13 (5), p.723
Hauptverfasser:	Ruscelli, Martina, Maloberti, Thais, Corradini, Angelo Gianluca, Rosini, Francesca, Querzoli, Giulia, Grillini, Marco, Altimari, Annalisa, Gruppioni, Elisa, Sanza, Viviana, Costantino, Alessia, Ciudino, Riccardo, Errani, Matteo, Papapietro, Alessia, Coluccelli, Sara, Turchetti, Daniela, Ferioli, Martina, Giunchi, Susanna, Dondi, Giulia, Tesei, Marco, Ravegnini, Gloria, Abbati, Francesca, Rubino, Daniela, Zamagni, Claudio, D'Angelo, Emanuela, De Iaco, Pierandrea, Santini, Donatella, Ceccarelli, Claudio, Perrone, Anna Myriam, Tallini, Giovanni, de Biase, Dario, De Leo, Antonio
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer Carcinoma Classification Clinical medicine Endometrium Gynecology Hysterectomy Immunohistochemistry Lymph nodes Lymphatic system Medical prognosis Mismatch repair Mutants Mutation Next-generation sequencing Oncology p53 Protein Pathology Patients Precision medicine Proteins Risk groups Software Surgery Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!